The first two authors contributed equally to this article.
Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomy
Version of Record online: 2 JUL 2013
© 2013 American Cancer Society
Volume 119, Issue 18, pages 3287–3294, 15 September 2013
How to Cite
Jackson, W., Hamstra, D. A., Johnson, S., Zhou, J., Foster, B., Foster, C., Li, D., Song, Y., Palapattu, G. S., Kunju, L. P., Mehra, R. and Feng, F. Y. (2013), Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomy. Cancer, 119: 3287–3294. doi: 10.1002/cncr.28215
- Issue online: 4 SEP 2013
- Version of Record online: 2 JUL 2013
- Manuscript Accepted: 21 MAY 2013
- Manuscript Revised: 14 MAY 2013
- Manuscript Received: 8 MAY 2013
- 16Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2–3,N0 disease and elevated PSA levels. J Clin Oncol. 2011;29:1., , , et al.
- 21Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiotherapy [published online ahead of print May 9, 2013]. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2013.03.028., , , et al.